Harnessing Cellular Immunity for Vaccination against Respiratory Viruses

Harnessing Cellular Immunity for Vaccination against Respiratory Viruses

Severe respiratory viral infections, such as influenza, metapneumovirus (HMPV), respiratory syncytial virus (RSV), rhinovirus (RV), and coronaviruses, including severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), cause significant mortality and morbidity worldwide. These viruses have been...

Full description

Bibliographic Details
Main Authors: Nicholas W. Lukacs, Carrie-Anne Malinczak
Format: Article
Language:English
Published: MDPI AG 2020-12-01
Series:Vaccines
Subjects:
vaccine
RSV
SARS-CoV-2
respiratory viruses
cellular immunity
nanoparticles
Online Access:https://www.mdpi.com/2076-393X/8/4/783

Internet

https://www.mdpi.com/2076-393X/8/4/783

Similar Items